Skip to content
  • Sunday, 26 July 2026
  • 6:35 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1289: Building a better hepatitis B trap
Microbiology & Immunology

TWiV 1289: Building a better hepatitis B trap

Lina Irawan Apr 16, 2026 0

The latest episode of "This Week in Virology" (TWiV), episode 1289, delves into two significant advancements in viral research: the…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 16, 2026 0

In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, in conversation with Vincent…

Read More
Microbiology & Immunology

TWiV 1291: A foot in the door for cytomegalovirus

Lina Irawan Apr 13, 2026 0

This week on "This Week in Virology" (TWiV), the podcast hosted by Vincent Racaniello, Alan Dove, Rich Condit, and Brianne…

Read More
Microbiology & Immunology

TWiV 1292: Clinical Update with Dr. Daniel Griffin

Lina Irawan Apr 12, 2026 0

In a stark assessment of the contemporary public health landscape, Dr. Daniel Griffin and Vincent Racaniello, host of the popular…

Read More
Microbiology & Immunology

TWiV 1293: The enemy of your parasite is your friend

Lina Irawan Apr 12, 2026 0

A recent episode of the podcast "This Week in Virology" (TWiV) delved into two significant scientific findings: the herd immunity…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 10, 2026 0

In a year-end clinical update, Dr. Daniel Griffin, in conversation with Vincent Racaniello on the “This Week in Virology” podcast,…

Read More
Microbiology & Immunology

TWiV 1285: Encapsidating Viruses 2025

Lina Irawan Apr 10, 2026 0

This Week in Virology (TWiV), a leading podcast in the field of microbiology, has released its 1285th episode, offering a…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin

Lina Irawan Apr 10, 2026 0

In a recent episode of "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, a prominent infectious disease clinician, and…

Read More
Microbiology & Immunology

TWiV 1287: Ancient Herpesviruses and Modern Dementia

Lina Irawan Apr 10, 2026 0

This Week in Virology (TWiV) podcast episode 1287, released on January 11, 2026, delved into two significant advancements in virology:…

Read More
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin Discusses Alarming Shifts in Childhood Immunization Schedules and Ongoing Public Health Concerns

Lina Irawan Apr 9, 2026 0

In a recent episode of the widely respected podcast "This Week in Virology" (TWiV), Dr. Daniel Griffin, a clinical expert,…

Read More

Posts pagination

1 … 13 14 15 … 18
Free and Accessible: A Five-Course Roadmap to Becoming a Proficient AI Practitioner in 2026Quantum Sensing with Diamond Defects Unlocks New Frontier in the Identification of Altermagnetic MaterialsUCSF Researchers Identify FTL1 Protein as Master Regulator of Hippocampal Aging and Potential Target for Reversing Memory LossAstrocyte networks in mice link distant brain regions in ways nerve cell wiring does not
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ